Comprehensive Medical Weight Loss
Shortly after recommending approval of Qnexa (Phentermine / Topiramate), the FDA advisory panel this week also voted to approve Arena Pharmaceuticals weight loss drug, Lorgess (Lorcacerin). This medication has been in clinical trials over the past several years and works…
Today the FDA announced that instead of reviewing Qnexa, the new weight loss drug by Vivus, combining Phentermine and Topiramate, they are pushing back the review date by 3 months to July 17th, 2012, to allow time to review all…
On February 22nd, 2012, the Advisory Committee to the FDA met to review a new weight loss drug, Qnexa. This drug is a combination of Phentermine and Topiramate, and the combination yields substantially better weight loss than Phentermine alone, even…
The FDA is again considering approval of an experimental weight loss drug it rejected a year ago over concerns about potential heart problems and birth defects in babies born to women who take the drug. California-based pharmaceutical company Vivus…
